Skip to content

Nuvation Bio

US · NUVB #2898 by market cap Listed 1970
3.80 -0.01 -0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Nuvation Bio

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Founded
2018
CEO
Dr. David T. Hung,M.D.
Employees
298
Headquarters
New York, New York, United States of America
Fiscal year end
12-31
Website
nuvationbio.com

Company profile

Exchange
US
Symbol
NUVB
Market-cap rank
#2898
Listing date
1970-01-01
Market cap
1.34B
Float cap
1.01B
Shares out
353.02M
Float shares
265.54M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Nuvation Bio discussion 0 comments

Add a comment